|
Prostate cancer diagnosed from
tissue sample in 90 seconds
The Fraunhofer Institute for
Ceramic Technologies and Systems (IKTS) in Dresden has developed a
device that can identify cancerous prostate tissue from a biopsy
within one and a half minutes by using laser stimulated
fluorescence. 14 Nov 2014
New technique to test for
prostate cancer
A team of researchers at Guangdong Medical
College in China has demonstrated the potential of a new test to
detect prostate cancer combining surface-enhanced Raman scattering
(SERS) with a new technique called support vector machine (SVM). 9
Sept 2014
Miniature kidney dialysis
machine can properly treat newborns for the first time
Italian scientists have developed a miniaturised kidney dialysis
machine capable of treating the smallest babies, and have for the
first time used it to safely treat a newborn baby with multiple
organ failure. 14 Jul 2014
£3.6m competition to develop kidney care technology
The UK Department of Health and the National Institute for Health
Research (NIHR) has launched a £3.6m fund to find new technologies associated with kidney
disease. 23 Oct 2013
Cook Medical introduces
Holmium laser system for urological procedures
Cook Medical
has announced that its H-30 Holmium urology laser system is
available in the United States and Europe. 19 Aug 2013
Personalising PSA test using
genetic tests could improve prostate cancer diagnosis
Testing
for genetic variants that can increase serum prostate specific
antigen (PSA) concentrations could avoid unnecessary biopsies for
some men and eliminate false complacency for others. 25 Apr 2013
Sutton Hospital invests in
shockwave technology to treat kidney stones
The device uses
shockwave technology to break apart the stones until they are small
enough for a patient to pass in their urine. This avoids the use of
invasive surgery or general anaesthetic. 20 Mar 2013
Elastography shows
promise for detecting cancers without biopsy
Researchers from the University of Oslo and Beaujon
University Hospital in Paris are to start clinical
trials of a new method for detecting cancer that
measures the elasticity of body tissue. 18 Feb 2013
New model helps predict chance of
surgical cure for prostate cancer
Prostate cancer experts have
developed an updated version of a statistical model, called the Partin
Tables, which helps assess the chance of a surgical cure for men
diagnosed with prostate cancer. 9 Jan 2013
Ultrasound test to replace invasive biopsy for liver fibrosis in NHS
A non-invasive ultrasound test is set to reduce the need for
liver biopsy across the NHS, saving over £500 on each test, following a
guide published by the NHS Technology Assessment Centre (NTAC).
Quality of French men's semen
falling
The concentration of sperm in French men’s semen was
in steady decline from 1989-2005 and there has been a decrease in
the number of normally formed sperm. 6 Dec 2012
Fourth new successful drug for
prostate cancer treatment in two years
Clinical trials have
shown the drug enzalutamide can significantly extend life and
improve quality of life in men with advanced prostate cancer. 15 Aug
2012
Electronic sensor can detect prostate
cancer cells
Scientists at the Barcelona University have
developed the main components of a biosensor containing several
hundred nanometric sized optoacoustic biosensors and that can detect
cancer cells in urine. 4 June 2012
Better treatment urgently
needed for end-stage kidney disease patients
A quarter of
end-stage kidney disease patients in Europe do not feel involved in
the decisions made about their own treatment choices. 24 May 2012
Antimicrobial coating for catheters could reduce costs of infections
An antimicrobial coating
made from positively charged compounds is being developed at Manchester University
to reduce infections from catheters.
Boston Scientific launches gel
to prevent stone migration in urologic procedures
Boston
Scientific has launched BackStop Gel, a new technology designed to
prevent stone migration during procedures used to break up and
retrieve urinary stones. 2 April 2012
D4D offers awards to develop
assistive and renal technologies
Devices For Dignity (D4D) is
offering £30,000 in a proof-of-concept competition designed to
accelerate the development of promising ideas in the healthcare
technology sector. 31 August 2011
A+PSA test gives better
results in testing for prostate cancer
A new test for
prostate cancer that measures levels of prostate specific antigen
(PSA) as well as six specific antibodies found in the blood of men
with the disease was more sensitive and more specific than the
conventional PSA test. 31 May 2011
New marker for prostate cancer
gives hope for more accurate diagnosis than PSA test
Researchers at Uppsala University have discovered a promising new
marker for diagnosing prostate cancer. Their unique method could
lead to more reliable diagnoses and fewer unnecessary operations. 18
May 2011
New prostate cancer drug
discovered by ICR approved by FDA
A drug for treating
metastatic prostate cancer discovered at The ICR has been approved
by the US FDA. Abiraterone acetate was invented by Professor Mike
Jarman and his colleagues at the Cancer Research UK Cancer
Therapeutics Unit. 18 May 2011
Natural cell protein suppresses
prostate cancer
Research at Imperial College London has found
that a naturally occurring protein called FUS inhibits the growth of
prostate cancer cells in the laboratory, and activates pathways that
lead to cell suicide. 22 Feb 2011
Microsulis sells microwave endometrial
ablation technology to Hologic
Microsulis Medical Limited is
to discontinue sales of its Microwave Endometrial Ablation system
for gynaecology and female urology and has licensed the technology
to Hologic Inc. 21 Feb 2011
Diffusion-weighted MRI shows
promise in detecting advancing prostate cancer
An advanced
type of magnetic resonance imaging — diffusion weighted MRI — could
be used instead of an invasive biopsy to decide whether prostate
cancer patients under active surveillance need treatment. 24 Jan
2011
Ultrasound shows if prostate
cancer biopsy or operation is necessary
A new technique that
uses microbubbles to highlight prostate cancer in ultrasound images
has the potential to assess how aggressive prostate tumours are and
indicate appropriate treatment. 21 Dec 2010
Prostate cell regulating protein can transform healthy cells into
cancer
The protein, called Bmi-1, has a crucial role in regulating the self-renewal of normal
prostate stem cells. It has now been found to
aid the transformation of healthy cells into prostate cancer cells.
9 Dec 2010
PSA blood test predicts risk of death
from prostate cancer
The PSA blood test commonly used to test for
prostate cancer can accurately predict the risk that a 60 year old man will
die from prostate cancer within the next 25 years. 23 Sept 2010
Natural orifice surgery removes
cancerous prostate through penis
Urologists at Mayo Clinic in Arizona
have developed a new surgical procedure for the treatment of prostate cancer
through the urethra, so that there is no incision on the body. [Includes
video] 12 August
2010
Prostate cancer seed cells discovered
New treatments for prostate cancer could result from the discovery that
basal cells found in benign prostate tissue can turn into cancer cells. 30
July 2010
Siemens Uroskop images entire urinary
tract with single exposure
The new dynamic flat detector technology
of UROSKOP Omnia enables the urologist to cover
the entire urinary tract (kidney, ureter, bladder) with only one
single exposure of exceptional image quality. 22 April 2010
HD 3D view in robotic surgery for
prostate cancer compensates for lack of touch
Robotic surgical
technology with its three-dimensional, high-definition view gives surgeons
the sensation of touch, even as they operate from a remote console. Outcomes
compare favourably with traditional invasive surgery. 21 April 2010
Siemens expands Clinitek point of care
urinalysis porfolio
Siemens Healthcare Diagnostics has launched the
Clinitek Status+ Analyser and the Clinitek Status Connect System for
urinalysis and pregnancy testing at the point of care. 2 April 2010
US HIFU to fund investigation of focal
therapy for prostate cancer in UK
The study, which will evaluate
quality of life outcomes and safety of focal therapy in the treatment of
localized prostate cancer will involve four centers initially and may expand
to as many as 10 centres in the UK. 9 Mar 2010
Breakthrough in real time tracking of
prostate motion during arc radiotherapy
US and Danish researchers
have devised a method for ‘real-time’ tracking of the prostate motion that
shows promise in paving the way for advanced clinical treatments. 9 Mar 2010
Similar outcomes from open and
laparoscopic prostate surgery
Researchers at the Memorial
Sloan-Kettering Cancer Center, New York compared outcomes in a population
based cohort of almost 6000 men 66 years of age or older with clinically
localized prostate cancer. 23 Feb 2010
Genetic abnormalities predict prostate
cancer survival
The combination of three genetic abnormalities
significantly impacts how long a prostate cancer patient is likely to
survive with the disease, according to scientists at the Institute of Cancer
Research (ICR). 22 Feb 2010
MR spectroscopy can locate sperm in
infertile men non-invasively
Magnetic resonance spectroscopy can be used to determine if men with no
sperm in their ejaculate still have sperm in their testes. It may remove the
need for invasive procedures. 9 Feb 2010
First evidence of virus in prostate
cancer cells
A type of virus known to cause leukemia and sarcomas in animals has been
found for the first time in malignant human prostate cancer cells. If it is
proven to cause the cancer it would open opportunities for developing
diagnostic tests, vaccines, and therapies for treatment. 11 Sep 2009
Three-way measurement improves
prediction of prostate cancer return
Cancer experts at Johns Hopkins University in the US have shown that a
three-way combination of measurements has the best chance yet of predicting
prostate disease metastasis. 24 July 2009
Combined drug, hormone and radiation
treatment cures prostate cancer
An experimental drug therapy used in combination with standardized hormone
treatment and radiation therapy has enabled two patients, whose prostate
cancer had been considered inoperable, to become cancer free. 8 July 2009
Focused ultrasound offers better
treatment for prostate cancer
An experimental treatment that uses ultrasound waves to kill prostate cancer
cells may be able to treat men without surgery, with fewer side effects and
with only a short stay in hospital, according to a UK study published in the
British Journal of Cancer. 2 July 2009
Prostate cancer translational research
in Europe: the search for biomarkers continues
Collaboration in prostate cancer translational research in Europe is not
only vital to sustain the progress achieved in recent years but also to
streamline current efforts between researchers and clinicians and avoid
duplication or overlaps. 29 June 2009
Rapid prostate cancer test based on
citrate levels in prostate samples
Researchers from the Universities of Durham and Maryland have developed a
test that uses light to measure citrate levels in samples from the prostate
gland. The technique could provide the basis of a rapid means of detecting
prostate cancer. 3 June 2009
European Association of Urology position statement on screening for
prostate cancer
Based on the results of the European Randomised Study for Screening
of Prostate Cancer (ERSPC), the EAU has formulated a position statement
regarding prostate cancer screening in Europe, and the subsequent
actions to be taken by health professionals and health authorities. 24
April 2009
Leicester University wins £320,000
grant to study magnetic nanoparticles for treatment of prostate cancer
The award will allow a multidisciplinary research team to design
high-performance magnetic nanoparticles that target unique cell surface
receptors present on the prostate tumour cell surface. 24 April 2009
BioImagene launches new Ki-67 algorithm
for prostate image analysis
The algorithm is used to detect and provide quantitative measurement of the
protein biomarker Ki-67. 9 April 2009
Allium's bulbar stent provides option
to treat patients with strictures
Allium Group's urethral bulbar stent enables urologists who are not experts
in urethral reconstructive surgery to treat patients with recurrent
strictures by inserting the urethral bulbar stent as an office outpatient
procedure. 25 March 2009
Mixed messages from prostate cancer
screening studies
Early data reported from the US PLCO study found there was no early
mortality benefit from annual prostate cancer screening. Alternatively,
long-term data from the ERSPC study show that screening reduced the rate of
mortality by 20%. 23 March 2009
Prostate cancer screening could cut
deaths by 20%
Screening for prostate cancer can reduce deaths by 20%, according to the
results of the European Randomized Study of Screening for Prostate Cancer
(ERSPC), the world's largest prostate cancer screening study. 23 March 2009
Freezing prostate cancer as effective
as surgery
Male lumpectomy, a minimally invasive interventional radiology treatment for
prostate cancer, is as effective as surgery in destroying diseased tumours
according to studies released at a meeting of the the Society of
Interventional Radiology. 19 March 2009
PSA test may be unnecessary for older
men
Certain men age 75 to 80 are unlikely to benefit from routine prostate
specific antigen (PSA) testing, according to a study by the Johns Hopkins
University School of Medicine. 23 February 2009
New indicator of prostate cancer
discovered
Researchers from the University of Michigan Comprehensive Cancer Center have
discovered that the presence of the chemical sarcosine appears to indicate
aggressive prostate cancer. 11 February 2009
Johnson Medtech’s non-magnetic motors
power world’s first MRI-guided prostate cancer treatment device
Johnson Medtech has announced its participation in creating the world’s
first MRI-compatible image-guided tumour treatment device with Profound
Medical Inc.(PMI). This revolutionary tissue coagulation device is expected
to treat prostate cancer in a fraction of the time and cost of existing
methods. 28 January 2009
Optimized radiation for prostate cancer therapy
In a cooperative study with Innsbruck Medical University and the
East-Vienna Center of Social Medicine, two physicists of Vienna
University of Technology (TU), evaluated the mean deviation of radiation
parameters for prostate cancers and compared various sources of
radiation. 23 October 2008 Deutsch
New catheter-less technique may ease pain
and discomfort after prostate cancer surgery
An innovative and patient-friendly approach that eliminates the use of a
penile urinary catheter can ease the pain of recovery following prostate
cancer surgery. The new patentable technique, used in conjunction with
robotic prostatectomy (the surgical removal of the prostate) eliminates the
pain and discomfort associated with the standard catheter. 16 October 2008
Demand for urinary incontinence devices in
Europe growing due to patient demand
The European urinary incontinence market is facing challenges such as lack
of sufficient clinical safety studies and price pressures due to intense
competition. However, rising awareness among the target patient population
and the introduction of innovative devices and techniques are sustaining
market expansion. 29 September 2008
Gyrus ACMI launches lightweight digital
nephroscope
Gyrus ACMI, a subsidiary of Olympus, has launched the Smith Digital
Percutaneous Nephroscope which features an ultra-miniature 1 mm CMOS imaging
sensor. 28 September 2008
Urinary abnormality successfully treated
with robot-assisted surgery
Robot-assisted laparoscopic surgery has been successfully used to repair
abnormal openings between the bladder and vagina known as fistulas, it is
reported in the online version of the Journal of Urology. 8 September
2008
New prostate cancer molecular test ready
for commercialization
US company Health Discovery Corporation has announced the completion of a
Phase III double-blind clinical trial of a new gene-based molecular
diagnostic test for prostate cancer. The company says the test is ready for
commercialization to be used by physicians on their patients at risk of
having prostate cancer. 27 August 2008
Prostate cryotherapy treatment available in UK
Prostate cryotherapy has recently been approved by the European
Association of Urologists (EAU) and has been used widely in the United
States for many years. It is now available in the UK at both NHS and
private hospitals. 27 August 2008
Allium Medical expands stent distribution
in Europe
Allium Medical Group has signed exclusive distribution deals for both its
ureteral and biliary stents with MenkeMed for the German and Austrian
markets and Ecce Dutoit for the Belgian, Dutch and Luxemburgian (Benelux)
markets. 14 July 2008
Minimally invasive prostate cancer
treatments underused in US and Europe
A survey by Millennium Research Group (MRG) of over 140 US and
European-based urologists suggests that several minimally invasive prostate
cancer treatment options are underused in both the US and Europe. 4 July
2008
Cryotherapy option for prostate cancer
treatment
Galil Medical has announced that the American Urological Association has
introduced clinical guidelines with best practice statements for prostate
cryotherapy. 23 May 2008
Identification of prostate cancer genes
opens door to new treatments
For the first time researchers have identified the genetic profile of
prostate cancer stem cells. The study by the YCR Cancer Research Unit at the
University of York, England, and Pro-cure Therapeutics Ltd, could lead to
new ways for treating the cancer. 22 May 2008
Microphone replaces catheter for detecting
benign prostatic enlargement
The sound of urinary flow detected using a microphone placed behind the
scrotum can measure the resistance placed on the urethra by an enlarged
prostate. 15 May 2008
Open access
journal on urology and urologic oncology launched
UroToday Inc. has launched UroToday International Journal (UIJ), a
new online, peer-reviewed, fast-tracked urology and urologic oncology
publication. 15 May 2008
Microwave treatments for enlarged prostate
cause blood pressure surges
Many men who receive microwave therapy for enlarged prostates experience
significant surges in blood pressure that could raise their risk of a heart
attack or stroke, according to new research findings published recently in
Mayo Clinic Proceedings. 18 April 2008
CyberKnife delivers high dose
brachytherapy for prostate cancer non-invasively
The CyberKnife robotic radiosurgery system can serve as a non-invasive means
for delivering high dose rate (HDR) brachytherapy dosing, according to a new
study. The study supports the system's clinical flexibility in treating
prostate cancer and expands the non-invasive options available to clinicians
and patients. 18 April 2008
Ultrasound diagnostic tool could improve
non-invasive treatment of prostate cancer
HistoScanning, a novel processing technology for ultrasonography could
improve the treatment and monitoring of prostate cancer and help avoid
unnecessary invasive procedures. 17 October 2007
 Metal-free
motor makes robotic biopsies safe for use with MRI
Engineers at the Johns Hopkins Urology Robotics Lab have developed a motor
without metal or electricity that can safely power remote-controlled robotic
surgical tools used for cancer biopsies and therapies guided by magnetic
resonance imaging. 17 April 2007
HIFU treatment for prostate cancer
maintains 100% continence and potency
A study at University College London Hospitals (UCLH) using the Sonablate
500 high-intensity focused ultrasound (HIFU) device to treat localised
prostate cancer has found it completely effective in maintaining continence
and potency. 3 April 2007
Siemens presents new lithotripter for
mobile urology platform
Siemens has added the Modularis Variostar lithotripter to its Modularis
urology platform. The module is suited to both overtable and undertable
procedures and a complete range of new ergonomic features simplifies
operation and daily work with the unit. 27 March 2007
B-K Medical introduces prostate transducer
with two ultrasound functions
A new transrectal prostate transducer from B-K Medical combines the
functionality of simultaneous biplane and endfire transducers in one. It
enables urologists to examine any prostate in any plane with control and
ease. 13 March 2007
Combination of radiation therapies more
effective treatment for prostate cancer
Studies have shown that a combination of different radiotherapeutic methods
are able to increase the efficacy of radiation for prostate cancer at an
early stage. Combined hormone and radiation therapy has also been shown to
benefit prostate cancer patients if they have a high risk of disease
progression. 27 Oct 2006
Siemens introduces Modularis VarioStar
lithotripsy system
The Modularis VarioStar is designed to offer the highest flexibility in
patient positioning and treatment, and to provide new ergonomic features for
clinicians. 29 August 2006
Bristol Hospital offers Sonablate
prostate cancer treatment on fee-per-use basis
Southmead Hospital, part of North Bristol NHS Trust in England, will offer
high intensity focused ultrasound (HIFU) treatment of prostate cancer using
the Sonablate 500 on a fee-per-use basis, joining 40 sites in the UK that
can make the treatment more widely available. 5 July 2006
Italian National Cancer Institute chooses
Ablatherm-HIFU to treat prostate cancer
The Italian National Cancer Institute, Centro Referimento Oncologico (CRO),
in cooperation with Pordenone Hospital in Aviano has chosen the
Ablatherm-HIFU technology from EDAP TMS S.A. for the treatment of prostate
cancer. 23 May 2006
Medtronic announces clinical trials
strategy for neurological and urological therapies
Medtronic will invest in at least six new major clinical trials of therapies
that use its neuromodulation or radiofrequency technology to treat a range
of neurological and urological conditions such as Parkinson's disease,
depression, chronic pain, severe spasticity. 1 May 2006
Ten years of high intensity focused
ultrasound treatment for prostate cancer
EDAP presented 10-year Ablatherm - HIFU European experiences and a review of
results of treatments dating back to 1995 at a special dedicated symposium
during the European Association of Urology conference in Paris, 5-8 April.
23 April 2006
Robotic prostatectomy protects sexual
function
A year-long study by Henry Ford Hospital found patients who underwent a
robotic radical prostatectomy had significantly better erectile function
outcomes than those who received conventional nerve-sparing surgery without
compromising cancer control. 11 January 2006
Photoselective vaporisation of the
prostate shown to be effective treatment for BPH
A study on the long-term outcomes of men treated with photoselective
vaporisation of the prostate (PVP) for benign prostatic hyperplasia (BPH)
using the Laserscope GreenLight (TM) laser system has shown significant and
sustainable improvements in the outcomes of patients. 28 September 2005
Microwave device treats enlarged prostates
faster, safer and effectively as surgery
Prostalund, a Swedish developer and manufacturer of medical devices,
announced its CoreTherm medical device that uses minimally invasive,
temperature-controlled, microwave thermotherapy to treat an enlarged
prostate. 28 May 2005
25th birthday of lithotripsy system
9 February 2005 marks the twenty-fifth anniversary of the first successful
treatment of a patient using Dornier's lithotripsy systems. This method is
easy on the patient, making open surgical operations superfluous, and it has
revolutionized the treatment of patients suffering from the stone. February
2005
Un'innovazione celebra il suo
25esimo compleanno
Se celebra el 25 aniversario de
una innovación científica
Le 25e anniversaire d'une
solution novatrice
Siemens launch new lithotripsy system:
Lithoskop, a multifunctional lithotripter for almost any urological
application. January 2005
Neues Lithotripsiesystem für nahezu
alle urologischen Anwendungen. Januar 2005
|
